He is a listed applicant on a patent application in relation to the use of fenofibrate for treatment of diabetic retinopathy. He holds no shares, stocks or options in any pharmaceutical company.
Type 2 diabetes often goes hand-in-hand with unhealthy cholesterol levels. Even someone with diabetes who has good control of their blood glucose is at a higher than average risk of having cholesterol ...